Modeling cancer processes with CRISPR-Cas9

被引：9

作者：

Lu, Xiao-Jie ^{[1
]}

Qi, Xiaolong ^{[2
,3
]}

Zheng, Dong-Hui ^{[4
]}

Ji, Li-Juan ^{[5
]}

机构：

[1] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Gastroenterol, Shanghai 200092, Peoples R China

[2] Zhengzhou Univ, Affiliated Hosp 1, Ctr Canc, Biotherapy Ctr, Zhengzhou 450052, Peoples R China

[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Gastroenterol & Hepatol, Shanghai 200092, Peoples R China

[4] Second Peoples Hosp Huaian, Dept Nephrol, Huaian, Peoples R China

[5] Second Peoples Hosp Huaian, Dept Rehabil, Huaian, Peoples R China

来源：

TRENDS IN BIOTECHNOLOGY | 2015年 / 33卷 / 06期

关键词：

GENOME; GENERATION; NUCLEASES; EVENTS;

D O I：

10.1016/j.tibtech.2015.03.007

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

CRISPR-Cas9 is an RNA-guided site-specific DNA editing tool which, together with its reprogrammed versions such as nickase Cas9 and dead Cas9, enables quick modeling of desired combinations of cancer-associated genomic and/or epigenetic aberrations simultaneously or sequentially, thus facilitating massive functional interrogations and therapy testing.

引用

页码：317 / 319

页数：3

共 50 条

[31] Gene editing for the treatment of lung cancer (CRISPR-Cas9)
Castillo, Andres
COLOMBIA MEDICA, 2016, 47 (04): : 178 - 180
[32] CRISPR-Cas9 Genetic Targeting of Metastatic Pancreatic Cancer
Bowland, Kirsten
Lai, Jiaying
Teh, Selina Shiqing K.
Bennett, Alexis
Skaist, Alyza
Zhang, Yan
Thompson, Elizabeth
Wheelan, Sarah J.
Hruban, Ralph H.
Karchin, Rachel
Iacobuzio-Donahue, Christine A.
Eshleman, James R.
MOLECULAR THERAPY, 2024, 32 (04) : 229 - 229
[33] CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment
Kaushik, Itishree
Ramachandran, Sharavan
Srivastava, Sanjay K.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2019, 96 : 4 - 12
[34] Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids
Mami Matano
Shoichi Date
Mariko Shimokawa
Ai Takano
Masayuki Fujii
Yuki Ohta
Toshiaki Watanabe
Takanori Kanai
Toshiro Sato
Nature Medicine, 2015, 21 : 256 - 262
[35] CRISPR-Cas9 strikes out in cassava
Rybicki, Edward P.
NATURE BIOTECHNOLOGY, 2019, 37 (07) : 727 - 728
[36] CRISPR-CAS9 in medicine, the saga continues
Becu-Villalobos, Damasia
MEDICINA-BUENOS AIRES, 2019, 79 (06) : 522 - 523
[37] Advances in therapeutic application of CRISPR-Cas9
Sun, Jinyu
Wang, Jianchu
Zheng, Donghui
Hu, Xiaorong
BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 164 - 174
[38] Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Behan, Fiona M.
Iorio, Francesco
Picco, Gabriele
Goncalves, Emanuel
Beaver, Charlotte M.
Migliardi, Giorgia
Santos, Rita
Rao, Yanhua
Sassi, Francesco
Pinnelli, Marika
Ansari, Rizwan
Harper, Sarah
Jackson, David Adam
Mcrae, Rebecca
Pooley, Rachel
Wilkinson, Piers
van der Meer, Dieudonne
Dow, David
Buser-Doepner, Carolyn
Bertotti, Andrea
Trusolino, Livio
Stronach, Euan A.
Saez-Rodriguez, Julio
Yusa, Kosuke
Garnett, Mathew J.
NATURE, 2019, 568 (7753) : 511 - +
[39] The CRISPR-Cas9 system in Neisseria spp
Zhang, Yan
PATHOGENS AND DISEASE, 2017, 75 (04):
[40] In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9
He, Zhi-Yao
Zhang, Ya-Guang
Yang, Yu-Han
Ma, Cui-Cui
Wang, Ping
Du, Wei
Li, Ling
Xiang, Rong
Song, Xiang-Rong
Zhao, Xia
Yao, Shao-Hua
Wei, Yu-Quan
HUMAN GENE THERAPY, 2018, 29 (02) : 223 - 233

← 1 2 3 4 5 →